A retrospective study of real-world effectiveness, safety and tolerability of perampanel in epilepsy patients with focal-onset and generalized-onset seizures
Latest Information Update: 27 May 2022
At a glance
- Drugs Perampanel (Primary)
- Indications Generalised seizures; Seizures
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Apr 2022 Results assessing effectiveness of adjunctive brivaracetam (BRV) in adults with focal seizures as measured by retention, presented at the 74th Annual Meeting of the American Academy of Neurology 2022.
- 26 Apr 2022 Results assessing perampanel (PER) when used as monotherapy in everyday clinical practice, presented at the 74th Annual Meeting of the American Academy of Neurology 2022.
- 18 Feb 2022 New trial record